Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer
Title:
Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer
Author:
Lohmann, Ana Elisa Chapman, Judy-Anne W. Burnell, Margot J. Levine, Mark Norman Tsvetkova, Elena Pritchard, Kathleen I. Gelmon, Karen A. O’Brien, Patti Han, Lei Rugo, Hope S. Albain, Kathy S. Perez, Edith A. Vandenberg, Theodore A. Chalchal, Haji I. Sawhney, Ravinder Pal Singh Shepherd, Lois E. Goodwin, Pamela Jean